Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuefu Zhuyu is a classic Traditional Chinese Medicine (TCM) herbal formula originally described in the Qing Dynasty text *Yi Lin Gai Cuo* (Correction of Errors in Medical Classics). It is primarily indicated for treating 'blood stasis in the chest' (Xue Fu), which in modern clinical practice corresponds to various cardiovascular conditions. The formula is a combination of 11 herbs: *Prunus persica* (Persicae Semen), *Carthamus tinctorius* (Carthami Flos), *Angelica sinensis* (Angelicae Sinensis Radix), *Rehmannia glutinosa* (Rehmanniae Radix), *Ligusticum chuanxiong* (Chuanxiong Rhizoma), *Paeonia lactiflora* (Paeoniae Radix Rubra), *Citrus aurantium* (Aurantii Fructus), *Platycodon grandiflorus* (Platycodonis Radix), *Bupleurum chinense* (Bupleuri Radix), *Achyranthes bidentata* (Achyranthis Bidentatae Radix), and *Glycyrrhiza uralensis* (Glycyrrhizae Radix et Rhizoma). It is widely used in China for the treatment of coronary heart disease, angina pectoris, and to aid recovery following percutaneous coronary intervention (PCI). Its pharmacological effects are attributed to anti-platelet, anti-inflammatory, and vasodilatory activities mediated by its diverse chemical constituents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xuefu zhuyu.